AP1976A - Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof - Google Patents
Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereofInfo
- Publication number
- AP1976A AP1976A AP2006003605A AP2006003605A AP1976A AP 1976 A AP1976 A AP 1976A AP 2006003605 A AP2006003605 A AP 2006003605A AP 2006003605 A AP2006003605 A AP 2006003605A AP 1976 A AP1976 A AP 1976A
- Authority
- AP
- ARIPO
- Prior art keywords
- disulfide
- sulfoxide
- sulfide
- sulfone derivatives
- cyclic sugars
- Prior art date
Links
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 title 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 title 1
- 235000000346 sugar Nutrition 0.000 title 1
- -1 sulfone derivatives of cyclic sugars Chemical class 0.000 title 1
- 150000003462 sulfoxides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200302368A ES2258365B1 (es) | 2003-10-03 | 2003-10-03 | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
| PCT/EP2004/010882 WO2005037842A1 (en) | 2003-10-03 | 2004-09-29 | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2006003605A0 AP2006003605A0 (en) | 2006-04-30 |
| AP1976A true AP1976A (en) | 2009-03-16 |
Family
ID=34451643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2006003605A AP1976A (en) | 2003-10-03 | 2004-09-29 | Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof |
Country Status (35)
| Country | Link |
|---|---|
| US (3) | US7521571B2 (es) |
| EP (1) | EP1668017B1 (es) |
| JP (2) | JP4809769B2 (es) |
| KR (1) | KR101141683B1 (es) |
| CN (1) | CN1863805B (es) |
| AP (1) | AP1976A (es) |
| AR (1) | AR045962A1 (es) |
| AT (1) | ATE423781T1 (es) |
| AU (1) | AU2004281916B2 (es) |
| BR (1) | BRPI0415020A (es) |
| CA (1) | CA2540500C (es) |
| DE (2) | DE602004019666D1 (es) |
| DK (1) | DK1668017T3 (es) |
| EA (1) | EA008942B1 (es) |
| EC (1) | ECSP066542A (es) |
| ES (2) | ES2258365B1 (es) |
| GB (1) | GB2421241B (es) |
| GE (1) | GEP20084490B (es) |
| GT (1) | GT200400200A (es) |
| HK (1) | HK1092807A1 (es) |
| HR (1) | HRP20090152T3 (es) |
| IL (1) | IL174371A0 (es) |
| IS (1) | IS8436A (es) |
| MX (1) | MXPA06003610A (es) |
| NO (1) | NO20061872L (es) |
| NZ (1) | NZ546043A (es) |
| PA (1) | PA8614201A1 (es) |
| PE (1) | PE20050436A1 (es) |
| PL (1) | PL1668017T3 (es) |
| PT (1) | PT1668017E (es) |
| RS (1) | RS20060241A (es) |
| SI (1) | SI1668017T1 (es) |
| UY (1) | UY28547A1 (es) |
| WO (1) | WO2005037842A1 (es) |
| ZA (1) | ZA200603475B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2258365B1 (es) | 2003-10-03 | 2007-12-01 | Lacer, S.A. | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
| EP1941876A1 (en) * | 2006-12-28 | 2008-07-09 | Lacer, S.A. | Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension |
| ES2332565B1 (es) * | 2007-01-23 | 2010-10-21 | Lacer, S.A. | Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios. |
| JP2010518170A (ja) * | 2007-02-13 | 2010-05-27 | ギリアード・パロ・アルト・インコーポレイテッド | 冠微小血管疾患の処置のためのラノラジンの使用 |
| US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
| US20080193530A1 (en) * | 2007-02-13 | 2008-08-14 | Brent Blackburn | Use of ranolazine for the treatment of non-coronary microvascular diseases |
| EP2136780A1 (en) * | 2007-02-13 | 2009-12-30 | CV Therapeutics Inc. | Use of ranolazine for the treatment of cardiovascular diseases |
| WO2008116083A1 (en) * | 2007-03-22 | 2008-09-25 | Cv Therapeutics, Inc. | Use of ranolazine for elevated brain-type natriuretic peptide |
| KR20100033490A (ko) * | 2007-05-31 | 2010-03-30 | 질레드 팔로 알토 인코포레이티드 | 상승된 뇌-형 나트륨이뇨 펩티드에 대한 라놀라진 |
| IE20070934A1 (en) | 2007-12-21 | 2009-06-24 | Trinity College Dublin | Efficient aspirin prodrugs |
| CA2706082C (en) * | 2008-02-07 | 2017-10-03 | Nicox S.A. | Nitric oxide donor compounds |
| EP2149577B1 (en) | 2008-07-22 | 2011-04-27 | Lacer, S.A. | New stereospecific method for the preparation of dioxa-bicyclooctane compounds |
| EP2149576A1 (en) * | 2008-07-22 | 2010-02-03 | Lacer, S.A. | Isosorbide Nitrates having vasodilating activity |
| EP2177216A1 (en) | 2008-10-13 | 2010-04-21 | Lacer, S.A. | Use of dianhydrohexite mononitrate derivatives as healing agents |
| WO2010055138A1 (en) * | 2008-11-14 | 2010-05-20 | Lacer, S.A. | New stereospecific method for the preparation of dioxa-bicyclooctane compounds |
| EP2199294A1 (en) | 2008-12-19 | 2010-06-23 | Lacer, S.A. | New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds |
| ES2587191T3 (es) * | 2009-12-23 | 2016-10-21 | Arca Biopharma, Inc. | Métodos y composiciones para enfermedades y afecciones cardiovasculares |
| FR2977252B1 (fr) * | 2011-06-30 | 2013-08-02 | Seppic Sa | Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament. |
| IN2014CN04434A (es) | 2011-12-16 | 2015-09-04 | 3M Innovative Properties Co | |
| BR112015021072A2 (pt) * | 2013-03-05 | 2017-07-18 | Archer Daniels Midland Co | processo de preparação de um monotriflato de isohexídeo, composto químico, processo para fabricação de um composto derivado de um monotriflato de isohexídeo, e, composto derivado |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0290885A2 (en) * | 1987-05-08 | 1988-11-17 | CHIESI FARMACEUTICI S.p.A. | 1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom |
| EP0530887A1 (fr) * | 1991-08-07 | 1993-03-10 | Laboratoires Hoechst S.A. | Nitrates organiques, leurs procédés de préparation et leur utilisation dans le traitement de maladies cardiovasculaires |
| WO2000020420A1 (es) * | 1998-10-07 | 2000-04-13 | Lacer, S.A. | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3886186A (en) | 1971-04-29 | 1975-05-27 | American Home Prod | Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol |
| GB1356374A (en) * | 1971-04-29 | 1974-06-12 | American Home Prod | Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol |
| DE3102947A1 (de) | 1981-01-29 | 1982-09-02 | Heinrich Mack Nachf., 7918 Illertissen | Verfahren zur herstellung von isosorbid-5-nitrat |
| US4891373A (en) * | 1988-11-23 | 1990-01-02 | Pfizer Inc. | Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments |
| ATE172183T1 (de) * | 1992-07-30 | 1998-10-15 | Cal Int Ltd | Ester und kombinationen von einem organischen nitrat und einem salicyclat |
| DE4410997A1 (de) * | 1994-03-30 | 1995-10-26 | Isis Pharma Gmbh | Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen |
| IL120531A (en) * | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
| WO2002034303A1 (en) * | 2000-10-27 | 2002-05-02 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| US20020013483A1 (en) * | 2000-07-13 | 2002-01-31 | Consortium Fur Elektrochemische Industrie Gmbh | Process for the preparation of dianhydrohexitol bisacylates |
| UA63467A (en) | 2003-04-22 | 2004-01-15 | Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture | |
| ES2258365B1 (es) * | 2003-10-03 | 2007-12-01 | Lacer, S.A. | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
-
2003
- 2003-10-03 ES ES200302368A patent/ES2258365B1/es not_active Expired - Fee Related
-
2004
- 2004-09-29 WO PCT/EP2004/010882 patent/WO2005037842A1/en active Application Filing
- 2004-09-29 EP EP04765682A patent/EP1668017B1/en not_active Expired - Lifetime
- 2004-09-29 PL PL04765682T patent/PL1668017T3/pl unknown
- 2004-09-29 EA EA200600694A patent/EA008942B1/ru not_active IP Right Cessation
- 2004-09-29 BR BRPI0415020-1A patent/BRPI0415020A/pt not_active IP Right Cessation
- 2004-09-29 DK DK04765682T patent/DK1668017T3/da active
- 2004-09-29 AP AP2006003605A patent/AP1976A/xx active
- 2004-09-29 PT PT04765682T patent/PT1668017E/pt unknown
- 2004-09-29 SI SI200431109T patent/SI1668017T1/sl unknown
- 2004-09-29 US US10/544,237 patent/US7521571B2/en not_active Expired - Fee Related
- 2004-09-29 GB GB0605574A patent/GB2421241B/en not_active Expired - Fee Related
- 2004-09-29 CN CN2004800289355A patent/CN1863805B/zh not_active Expired - Fee Related
- 2004-09-29 DE DE602004019666T patent/DE602004019666D1/de not_active Expired - Lifetime
- 2004-09-29 GE GEAP20049372A patent/GEP20084490B/en unknown
- 2004-09-29 NZ NZ546043A patent/NZ546043A/en unknown
- 2004-09-29 JP JP2006530042A patent/JP4809769B2/ja not_active Expired - Fee Related
- 2004-09-29 MX MXPA06003610A patent/MXPA06003610A/es active IP Right Grant
- 2004-09-29 RS YUP-2006/0241A patent/RS20060241A/sr unknown
- 2004-09-29 KR KR1020067006283A patent/KR101141683B1/ko not_active IP Right Cessation
- 2004-09-29 AT AT04765682T patent/ATE423781T1/de not_active IP Right Cessation
- 2004-09-29 AU AU2004281916A patent/AU2004281916B2/en not_active Ceased
- 2004-09-29 ES ES04765682T patent/ES2322468T3/es not_active Expired - Lifetime
- 2004-09-29 DE DE112004001860T patent/DE112004001860T5/de not_active Withdrawn
- 2004-09-29 CA CA2540500A patent/CA2540500C/en not_active Expired - Fee Related
- 2004-09-30 PE PE2004000957A patent/PE20050436A1/es not_active Application Discontinuation
- 2004-10-01 AR ARP040103576A patent/AR045962A1/es unknown
- 2004-10-01 GT GT200400200A patent/GT200400200A/es unknown
- 2004-10-01 UY UY28547A patent/UY28547A1/es not_active Application Discontinuation
- 2004-10-01 PA PA20048614201A patent/PA8614201A1/es unknown
-
2006
- 2006-03-16 IL IL174371A patent/IL174371A0/en unknown
- 2006-04-27 NO NO20061872A patent/NO20061872L/no not_active Application Discontinuation
- 2006-05-02 ZA ZA200603475A patent/ZA200603475B/xx unknown
- 2006-05-03 EC EC2006006542A patent/ECSP066542A/es unknown
- 2006-05-03 IS IS8436A patent/IS8436A/is unknown
- 2006-12-13 HK HK06113705.3A patent/HK1092807A1/xx unknown
-
2009
- 2009-03-09 US US12/400,394 patent/US7777058B2/en not_active Expired - Fee Related
- 2009-03-16 HR HR20090152T patent/HRP20090152T3/xx unknown
-
2010
- 2010-04-06 US US12/755,103 patent/US8541607B2/en not_active Expired - Fee Related
- 2010-10-08 JP JP2010228789A patent/JP2011012081A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0290885A2 (en) * | 1987-05-08 | 1988-11-17 | CHIESI FARMACEUTICI S.p.A. | 1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom |
| EP0530887A1 (fr) * | 1991-08-07 | 1993-03-10 | Laboratoires Hoechst S.A. | Nitrates organiques, leurs procédés de préparation et leur utilisation dans le traitement de maladies cardiovasculaires |
| WO2000020420A1 (es) * | 1998-10-07 | 2000-04-13 | Lacer, S.A. | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200603475B (en) | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof | |
| DE60304325D1 (de) | Geschlossene kapsel mit öffnungsmittel | |
| HK1088620A1 (en) | Sulfide-containing polythiols | |
| ATE556593T1 (de) | Herbizide enthaltend substituierte thien-3-yl- sulfonylamino(thio)carbonyltriazolin(thi)one und flurtamone | |
| NO20053564D0 (no) | Bis(3)-alkoksyalkan-2-ol)sulfider, sulfoner og sulfoksider: nye overflateaktive midler. | |
| ATE407172T1 (de) | Schwefelpellet mit h2s-unterdrückungsmittel | |
| PL1725100T3 (pl) | Herbicydy na bazie podstawionych tien-3-ylo-sulfonylo-amino(tio)karbonylotriazolin(ti)onów i inhibitorów 4-HPPD | |
| ATE354566T1 (de) | Aromatische sulfone und deren medizinische verwendung | |
| DK1896401T3 (da) | Syntese af umættede sulfider, sulfoner, sulfoxider og sulfonamider | |
| EP2046322A4 (en) | ARYL VINYL SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES, DERIVATIVES THEREOF AND THERAPEUTIC USES THEREOF | |
| DE60304513D1 (de) | Flügelprofil und -aufbau | |
| ATE412645T1 (de) | Substituierte thiophene und deren verwendungen | |
| DE60310998D1 (de) | Ladebrücke, ladebrückenverlängerung und verlängerungsscharnieranordnung | |
| ITMI20020772A0 (it) | Meccanismo per ante scorrevoli | |
| DE50308900D1 (de) | Bis-o-amino(thio)phenole und deren Herstellung | |
| ITMI20020597A0 (it) | Derivati del probucolo | |
| AP2022A (en) | Pesticidal treatment of stored foodstuffs, chambers, structures and works of art with sulphur compounds | |
| AU2003233892A1 (en) | Methods of carbon disulfide treatment | |
| AU2003265069A8 (en) | Wing structure | |
| EP1594381A4 (en) | SNAPPING AND JOINT ARRANGEMENTS, WATCHES AND APPROPRIATE PROCEDURES | |
| AU2003293573A1 (en) | Bow limb fixation member | |
| HK1110860A1 (en) | Sulfonyl amino cyclic derivatives and use thereof | |
| TW517772U (en) | Integral structure of auto-door with capable of overall open function | |
| TW545129U (en) | Multi-section foldable stick | |
| TW551405U (en) | Pivot structure of air gates |